title: The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks.
abstract: Recent studies suggest that involving pharmacists is an effective strategy for improving patient adherence and blood pressure (BP) control. To date, few controlled studies have tested the cost-effectiveness of specific models for improving patient adherence and BP control in community pharmacies, where most Americans obtain prescriptions. We hypothesized that a team model of adherence monitoring and intervention in corporately owned community pharmacies can improve patient adherence, prescribing, and BP control among hypertensive black patients. The Team Education and Adherence Monitoring (TEAM) Trial is a randomized controlled trial testing a multistep intervention for improving adherence monitoring and intervention in 28 corporately owned community pharmacies. Patients in the 14 control pharmacies received "usual care," and patients in the 14 intervention pharmacies received TEAM Care by trained pharmacists and pharmacy technicians working with patients and physicians. Data collectors screened 1250 patients and enrolled 597 hypertensive black patients. The primary end points were the proportion of patients achieving BP control and reductions in systolic and diastolic BP measured after 6 and 12 months. Secondary end points were changes in adherence monitoring and intervention, patient adherence and barriers to adherence, prescribing, and cost-effectiveness. Researchers also will examine potential covariates and barriers to change. Involving pharmacists is a potentially powerful means of improving BP control in blacks. Pharmacists are in an excellent position to monitor patients between clinic visits and to provide useful information to patients and physicians.
authors.affiliation: Social and Administrative Sciences, University of Wisconsin-Madison, Madison, Wis 53705, USA. blsvarstad@pharmacy.wisc.edu
authors.forename: Bonnie L
authors.initials: BL
authors.lastname: Svarstad
authors.forename: Jane Morley
authors.initials: JM
authors.lastname: Kotchen
authors.forename: Theresa I
authors.initials: TI
authors.lastname: Shireman
authors.forename: Stephanie Y
authors.initials: SY
authors.lastname: Crawford
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Palmer
authors.forename: Eva M
authors.initials: EM
authors.lastname: Vivian
authors.forename: Roger L
authors.initials: RL
authors.lastname: Brown
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D044383:Black People; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000208:ethnology; D055118:Medication Adherence; D010348:Patient Care Team; D010353:Patient Education as Topic; D010594:Pharmacies; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
chemical_list: D000959:Antihypertensive Agents